# Pilot Study to Evaluate the Duration of Effects on Simulated Car Driving and Cognitive Performance After a Single Dose of JNJ-42847922, Zolpidem and Placebo in Healthy Participants

> **NCT02578472** · PHASE1 · COMPLETED · sponsor: **Janssen-Cilag International NV** · enrollment: 36 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** JNJ-42847922
- **DRUG:** Zolpidem
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02578472
- **Lead sponsor:** Janssen-Cilag International NV
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-11
- **Primary completion:** 2016-02
- **Final completion:** 2016-02
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2016-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02578472

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02578472, "Pilot Study to Evaluate the Duration of Effects on Simulated Car Driving and Cognitive Performance After a Single Dose of JNJ-42847922, Zolpidem and Placebo in Healthy Participants". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02578472. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*